Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study

Moreau, P (author)

Facon, T (author)

Usmani, S (author)

show more...

Bahlis, NJ (author)

Raje, N (author)

Plesner, T (author)

Orlowski, RZ (author)

Basu, S (author)

Nahi, H (author)

Karolinska Institutet

Hulin, C (author)

Quach, H (author)

Goldschmidt, H (author)

O'Dwyer, M (author)

Perrot, A (author)

Venner, CP (author)

Weisel, K (author)

Tiab, M (author)

Macro, M (author)

Frenzel, L (author)

Leleu, X (author)

Pei, HL (author)

Krevvata, M (author)

Carson, R (author)

Borgsten, F (author)

Kumar, SK (author)

show less...

 (creator_code:org_t)

American Society of Hematology, 2022

2022

English.

In: BLOOD. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 140, s. 7297-7300

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Conference paper (other academic/artistic)